{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:06:13Z","timestamp":1793646373565,"version":"4.5.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00198-013-2313-x","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T10:11:52Z","timestamp":1362564712000},"page":"2377-2386","source":"Crossref","is-referenced-by-count":332,"title":["NF-\u03baB signaling and bone resorption"],"prefix":"10.1007","volume":"24","author":[{"given":"Y.","family":"Abu-Amer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"2313_CR1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.1079331","volume":"298","author":"AY Ting","year":"2002","unstructured":"Ting AY, Endy D (2002) Signal transduction: decoding NF-kB signaling. Science 298:1189\u20131190","journal-title":"Science"},{"key":"2313_CR2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin Jr","year":"1996","unstructured":"Baldwin AS Jr (1996) The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol 14:649\u2013683 [Review; 180 refs]","journal-title":"Annu Rev Immunol"},{"key":"2313_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","volume":"87","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Baltimore D (1996) NF-kB: ten years after. Cell 87:13\u201320","journal-title":"Cell"},{"key":"2313_CR4","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S (2004) Signaling to NF-kB. Genes Dev 18:2195\u20132224","journal-title":"Genes Dev"},{"key":"2313_CR5","first-page":"4333","volume":"89","author":"U Siebenlist","year":"2001","unstructured":"Siebenlist U, Franzoso G (2001) Structure, regulation and function of NF-kB. Proc Natl Acad Sci U S A 89:4333\u20134337","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2313_CR6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80413-4","volume":"91","author":"I Stancovski","year":"1997","unstructured":"Stancovski I, Baltimore D (1997) NF-kB activation: the IkB kinase revealed? Cell 91:299\u2013302","journal-title":"Cell"},{"key":"2313_CR7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.278.5339.866","volume":"278","author":"J Woronicz","year":"1997","unstructured":"Woronicz J, Gao X, Cao Z, Rothe M, Goeddel D (1997) IkB kinase-beta: NF-kB activation and complex formation with IkB kinase-alpha and NIK. Science 278:866\u2013869","journal-title":"Science"},{"key":"2313_CR8","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.281.5381.1360","volume":"281","author":"E Zandi","year":"1998","unstructured":"Zandi E, Chen Y, Karin M (1998) Direct phosphorylation of IkB by IKKa and IKKb: discrimination between free and NF-kB-bound substrate. Science 281:1360\u20131363","journal-title":"Science"},{"key":"2313_CR9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI17337","volume":"113","author":"C Fan","year":"2004","unstructured":"Fan C, Li Q, Zhang Y, Liu X, Luo M, Abbott D, Zhou W, Engelhardt JF (2004) I{kappa}B{alpha} and IkB-beta possess injury context-specific functions that uniquely influence hepatic NF-kB induction and inflammation. J Clin Invest 113:746\u2013755","journal-title":"J Clin Invest"},{"key":"2313_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8:49\u201362","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2313_CR11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280\u2013288","journal-title":"Trends Immunol"},{"key":"2313_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","volume":"3","author":"M Karin","year":"2004","unstructured":"Karin M, Yamamoto Y, Wang M (2004) The IKK NF-kB system: a treasure trove for drug development. Nat Rev 3:17\u201326","journal-title":"Nat Rev"},{"key":"2313_CR13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","volume":"3","author":"V Iotsova","year":"1997","unstructured":"Iotsova V, Caama\u00e4no J, Loy J, Yang Y, Lewin A, Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285\u20131289","journal-title":"Nat Med"},{"key":"2313_CR14","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","volume":"11","author":"G Franzoso","year":"1997","unstructured":"Franzoso G, Carlson L, Poljak L, Shores E, Brown K, Leonardi A, Tran T, Boyce B, Siebenlist U (1997) Requirment for NF-kB in osteoclast and B-cell development. Genes Dev 11:3482\u20133496","journal-title":"Genes Dev"},{"key":"2313_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(99)00105-2","volume":"25","author":"B Boyce","year":"1999","unstructured":"Boyce B, Xing L, Fransozo G, Siebenlist U (1999) Required and nonessential functions of nuclear factor-kB in bone cells. Bone 25:137\u2013139","journal-title":"Bone"},{"key":"2313_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira DSA, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315\u2013323","journal-title":"Nature"},{"key":"2313_CR17","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci U S A 95:3597\u20133602","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2313_CR18","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/en.142.12.5050","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S (2001) Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142:5050\u20135055","journal-title":"Endocrinology"},{"key":"2313_CR19","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci 97:1566\u20131571","journal-title":"Proc Natl Acad Sci"},{"key":"2313_CR20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1097-2765(00)80232-4","volume":"4","author":"BR Wong","year":"1999","unstructured":"Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y (1999) TRANCE, a TNF family member, activates Akt\/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4:1041\u20131049","journal-title":"Mol Cell"},{"key":"2313_CR21","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.4049\/jimmunol.162.5.2562","volume":"162","author":"R Josien","year":"1999","unstructured":"Josien R, Wong BR, Li HL, Steinman RM, Choi Y (1999) TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 162:2562\u20132568","journal-title":"J Immunol"},{"key":"2313_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(99)00105-2","volume":"25","author":"BF Boyce","year":"1999","unstructured":"Boyce BF, Xing L, Franzoso G, Siebenlist U (1999) Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone 25:137\u2013139","journal-title":"Bone"},{"key":"2313_CR23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1568008054863808","volume":"5","author":"Y Abu-Amer","year":"2005","unstructured":"Abu-Amer Y (2005) Advances in osteoclast differentiation and function. Curr Drug Targets Immune Endocr Metabol Disord 5:347\u2013355","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"2313_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","volume":"7","author":"G Xiao","year":"2001","unstructured":"Xiao G, Harhaj EW, Sun SC (2001) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7:401\u2013409","journal-title":"Mol Cell"},{"key":"2313_CR25","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.167.10.5895","volume":"167","author":"C Smith","year":"2001","unstructured":"Smith C, Andreakos E, Crawley JB, Brennan FM, Feldmann M, Foxwell BM (2001) NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts. J Immunol 167:5895\u20135903","journal-title":"J Immunol"},{"key":"2313_CR26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0765.2010.01333.x","volume":"46","author":"NS Soysa","year":"2011","unstructured":"Soysa NS, Alles N, Takahashi M, Aoki K, Ohya K (2011) Defective nuclear factor-kappaB-inducing kinase in aly\/aly mice prevents bone resorption induced by local injection of lipopolysaccharide. J Periodontal Res 46:280\u2013284","journal-title":"J Periodontal Res"},{"key":"2313_CR27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1359\/jbmr.091030","volume":"25","author":"NS Soysa","year":"2010","unstructured":"Soysa NS, Alles N, Weih D, Lovas A, Mian AH, Shimokawa H, Yasuda H, Weih F, Jimi E, Ohya K, Aoki K (2010) The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J Bone Miner Res 25:809\u2013818","journal-title":"J Bone Miner Res"},{"key":"2313_CR28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.278.5339.860","volume":"278","author":"F Mercurio","year":"1997","unstructured":"Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278:860\u2013866","journal-title":"Science"},{"key":"2313_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)80344-X","volume":"90","author":"C Regnier","year":"1997","unstructured":"Regnier C, Song H, Gao X, Goeddel D, Cao Z, Rothe M (1997) Identification and characterization of an I-kB kinase. Cell 90:373\u2013383","journal-title":"Cell"},{"key":"2313_CR30","doi-asserted-by":"crossref","first-page":"54841","DOI":"10.1074\/jbc.M406392200","volume":"279","author":"ML Chaisson","year":"2004","unstructured":"Chaisson ML, Branstetter DG, Derry JM, Armstrong AP, Tometsko ME, Takeda K, Akira S, Dougall WC (2004) Osteoclast differentiation is impaired in the absence of IkB kinase-alpha. J Biol Chem 279:54841\u201354848","journal-title":"J Biol Chem"},{"key":"2313_CR31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","volume":"201","author":"MG Ruocco","year":"2005","unstructured":"Ruocco MG, Maeda S, Park JM, Lawrence T, Hsu L-C, Cao Y, Schett G, Wagner EF, Karin M (2005) IkB kinase-beta, but not IKK-alpha, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med 201:1677\u20131687","journal-title":"J Exp Med"},{"key":"2313_CR32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20030116","volume":"198","author":"DV Novack","year":"2003","unstructured":"Novack DV, Yin L, Hagen-Stapleton A, Schreiber RD, Goeddel DV, Ross FP, Teitelbaum SL (2003) The I-kappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med 198:771\u2013781","journal-title":"J Exp Med"},{"key":"2313_CR33","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1073\/pnas.0708576105","volume":"105","author":"S Vaira","year":"2008","unstructured":"Vaira S, Johnson T, Hirbe AC, Alhawagri M, Anwisye I, Sammut B, O'Neal J, Zou W, Weilbaecher KN, Faccio R, Novack DV (2008) RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci U S A 105:3897\u20133902","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2313_CR34","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.167.10.5895","volume":"167","author":"C Smith","year":"2001","unstructured":"Smith C, Andreakos E, Crawley JB, Brennan FM, Feldmann M, Foxwell BM (2001) NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts. J Immunol 167:5895\u20135903","journal-title":"J Immunol"},{"key":"2313_CR35","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI38716","volume":"119","author":"Z Yao","year":"2009","unstructured":"Yao Z, Xing L, Boyce BF (2009) NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J Clin Invest 119:3024\u20133034","journal-title":"J Clin Invest"},{"key":"2313_CR36","doi-asserted-by":"crossref","first-page":"24546","DOI":"10.1074\/jbc.M800434200","volume":"283","author":"JE Otero","year":"2008","unstructured":"Otero JE, Dai S, Foglia D, Alhawagri M, Vacher J, Pasparakis M, Abu-Amer Y (2008) Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem 283:24546\u201324553","journal-title":"J Biol Chem"},{"key":"2313_CR37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4","volume":"25","author":"JE Otero","year":"2010","unstructured":"Otero JE, Dai S, Alhawagri MA, Darwech I, Abu-Amer Y (2010) IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis. J Bone Miner Res 25:1282\u20131294","journal-title":"J Bone Miner Res"},{"key":"2313_CR38","doi-asserted-by":"crossref","first-page":"e38694","DOI":"10.1371\/journal.pone.0038694","volume":"7","author":"JE Otero","year":"2012","unstructured":"Otero JE, Chen T, Zhang K, Abu-Amer Y (2012) Constitutively active canonical NF-kappaB pathway induces severe bone loss in mice. PLoS One 7:e38694","journal-title":"PLoS One"},{"issue":"Suppl 4","key":"2313_CR39","doi-asserted-by":"crossref","first-page":"iv81","DOI":"10.1136\/ard.2005.042721","volume":"64","author":"MG Ruocco","year":"2005","unstructured":"Ruocco MG, Karin M (2005) IKK{beta} as a target for treatment of inflammation induced bone loss. Ann Rheum Dis 64(Suppl 4):iv81\u2013iv85","journal-title":"Ann Rheum Dis"},{"key":"2313_CR40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-0-387-72009-8_16","volume":"602","author":"MG Ruocco","year":"2007","unstructured":"Ruocco MG, Karin M (2007) Control of osteoclast activity and bone loss by IKK subunits: new targets for therapy. Adv Exp Med Biol 602:125\u2013134","journal-title":"Adv Exp Med Biol"},{"key":"2313_CR41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bmcl.2003.10.047","volume":"14","author":"AH Bingham","year":"2004","unstructured":"Bingham AH, Davenport RJ, Gowers L, Knight RL, Lowe C, Owen DA, Parry DM, Pitt WR (2004) A novel series of potent and selective IKK2 inhibitors. Bioorg Med Chem Lett 14:409\u2013412","journal-title":"Bioorg Med Chem Lett"},{"key":"2313_CR42","doi-asserted-by":"crossref","first-page":"45992","DOI":"10.1074\/jbc.M206494200","volume":"277","author":"MJ May","year":"2002","unstructured":"May MJ, Marienfeld RB, Ghosh S (2002) Characterization of the Ikappa B-kinase NEMO binding domain. J Biol Chem 277:45992\u201346000","journal-title":"J Biol Chem"},{"key":"2313_CR43","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2002-09-2960","volume":"102","author":"M Choi","year":"2003","unstructured":"Choi M, Rolle S, Wellner M, Cardoso MC, Scheidereit C, Luft FC, Kettritz R (2003) Inhibition of NF-kB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 102:2259\u20132267","journal-title":"Blood"},{"key":"2313_CR44","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jor.20184","volume":"24","author":"JC Clohisy","year":"2006","unstructured":"Clohisy JC, Yamanaka Y, Faccio R, Abu-Amer Y (2006) Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis. J Orthop Res 24:1358\u20131365","journal-title":"J Orthop Res"},{"key":"2313_CR45","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.C400258200","volume":"279","author":"S Dai","year":"2004","unstructured":"Dai S, Hirayama T, Abbas S, Abu-Amer Y (2004) The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279:37219\u201337222","journal-title":"J Biol Chem"},{"key":"2313_CR46","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.4049\/jimmunol.179.5.2681","volume":"179","author":"W Shibata","year":"2007","unstructured":"Shibata W, Maeda S, Hikiba Y, Yanai A, Ohmae T, Sakamoto K, Nakagawa H, Ogura K, Omata M (2007) Cutting edge: the I{kappa}B Kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J Immunol 179:2681\u20132685","journal-title":"J Immunol"},{"key":"2313_CR47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/eji.200425956","volume":"35","author":"SW Tas","year":"2005","unstructured":"Tas SW, de Jong EC, Hajji N, May MJ, Ghosh S, Vervoordeldonk MJ, Tak PP (2005) Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization. Eur J Immunol 35:1164\u20131174","journal-title":"Eur J Immunol"},{"key":"2313_CR48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajpath.2010.12.009","volume":"178","author":"A Wysong","year":"2011","unstructured":"Wysong A, Couch M, Shadfar S, Li L, Rodriguez JE, Asher S, Yin X, Gore M, Baldwin A, Patterson C, Willis MS (2011) NF-\u03baB inhibition protects against tumor-induced cardiac atrophy in vivo. Am J Pathol 178:1059\u20131068","journal-title":"Am J Pathol"},{"key":"2313_CR49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm1054","volume":"10","author":"E Jimi","year":"2004","unstructured":"Jimi E, Aoki K, Saito H, D'Acquisto F, May MJ, Nakamura I, Sudo T, Kojima T, Okamoto F, Fukushima H, Okabe K, Ohya K, Ghosh S (2004) Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med 10:617\u2013624","journal-title":"Nat Med"},{"key":"2313_CR50","doi-asserted-by":"crossref","first-page":"45528","DOI":"10.1074\/jbc.M408579200","volume":"279","author":"MJ May","year":"2004","unstructured":"May MJ, Larsen SE, Shim JH, Madge LA, Ghosh S (2004) A novel ubiquitin-like domain in Ikappa B-kinase beta is required for functional activity of the kinase. J Biol Chem 279:45528\u201345539","journal-title":"J Biol Chem"},{"key":"2313_CR51","doi-asserted-by":"crossref","first-page":"25522","DOI":"10.1074\/jbc.M110.121533","volume":"285","author":"I Darwech","year":"2010","unstructured":"Darwech I, Otero JE, Alhawagri MA, Abu-Amer Y (2010) Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis. J Biol Chem 285:25522\u201325530","journal-title":"J Biol Chem"},{"key":"2313_CR52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4914(01)02154-2","volume":"7","author":"G Courtois","year":"2001","unstructured":"Courtois G, Smahi A, Israel A (2001) NEMO\/IKK-gamma: linking NF-kB to human disease. Trends Mol Med 7:427\u2013430","journal-title":"Trends Mol Med"},{"key":"2313_CR53","doi-asserted-by":"crossref","unstructured":"Hacker H, and Karin M (2006) Regulation and function of IKK and IKK-related kinases. Science's Stke [Electronic Resource]: Signal Transduction Knowledge Environment 2006, re13","DOI":"10.1126\/stke.3572006re13"},{"key":"2313_CR54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ncb0204-89","volume":"6","author":"R Hay","year":"2004","unstructured":"Hay R (2004) Modifiying NEMO. Nat Cell Biol 6:89\u201391","journal-title":"Nat Cell Biol"},{"key":"2313_CR55","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1074\/jbc.M008353200","volume":"276","author":"XH Li","year":"2001","unstructured":"Li XH, Fang X, Gaynor RB (2001) Role of IKK-gamma \/NEMO in assembly of the IkB kinase complex. J Biol Chem 276:4494\u20134500","journal-title":"J Biol Chem"},{"key":"2313_CR56","doi-asserted-by":"crossref","first-page":"R1040","DOI":"10.1016\/j.cub.2004.11.040","volume":"14","author":"KA Burns","year":"2004","unstructured":"Burns KA, Martinon F (2004) Inflammatory diseases: is ubiquitinated NEMO at the hub? Curr Biol 14:R1040\u2013R1042","journal-title":"Curr Biol"},{"key":"2313_CR57","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1074\/jbc.M806655200","volume":"284","author":"F Cordier","year":"2009","unstructured":"Cordier F, Grubisha O, Traincard F, V\u00e9ron M, Delepierre M, Agou F (2009) The zinc finger of NEMO is a functional ubiquitin-binding domain. J Biol Chem 284:2902\u20132907","journal-title":"J Biol Chem"},{"key":"2313_CR58","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4161\/cbt.5.10.3289","volume":"5","author":"H Kawadler","year":"2006","unstructured":"Kawadler H, Yang X (2006) Lys63-linked polyubiquitin chains: linking more than just ubiquitin. Cancer Biol Ther 5:1273\u20131274","journal-title":"Cancer Biol Ther"},{"key":"2313_CR59","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/emboj.2009.241","volume":"28","author":"E Laplantine","year":"2009","unstructured":"Laplantine E, Fontan E, Chiaravalli J, Lopez T, Lakisic G, Veron M, Agou F, Israel A (2009) NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J 28:2885\u20132895","journal-title":"EMBO J"},{"key":"2313_CR60","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","volume":"26","author":"A Adhikari","year":"2007","unstructured":"Adhikari A, Xu M, Chen ZJ (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26:3214\u20133226","journal-title":"Oncogene"},{"key":"2313_CR61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.molcel.2009.01.014","volume":"33","author":"ZJ Chen","year":"2009","unstructured":"Chen ZJ, Sun LJ (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33:275\u2013286","journal-title":"Mol Cell"},{"key":"2313_CR62","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00018-010-0404-9","volume":"67","author":"J Gautheron","year":"2010","unstructured":"Gautheron J, Courtois G (2010) \u201cWithout Ub I am nothing\u201d: NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation. Cell Mol Life Sci 67:3101\u20133113","journal-title":"Cell Mol Life Sci"},{"key":"2313_CR63","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.4049\/jimmunol.180.11.7107","volume":"180","author":"C-Y Ni","year":"2008","unstructured":"Ni C-Y, Wu Z-H, Florence WC, Parekh VV, Arrate MP, Pierce S, Schweitzer B, Van Kaer L, Joyce S, Miyamoto S, Ballard DW, Oltz EM (2008) Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo. J Immunol 180:7107\u20137111","journal-title":"J Immunol"},{"key":"2313_CR64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ncb1821","volume":"11","author":"F Tokunaga","year":"2009","unstructured":"Tokunaga F, Sakata S-I, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, Yamamoto M, Akira S, Takao T, Tanaka K, Iwai K (2009) Involvement of linear polyubiquitylation of NEMO in NF-[kappa]B activation. Nat Cell Biol 11:123\u2013132","journal-title":"Nat Cell Biol"},{"key":"2313_CR65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nature02273","volume":"427","author":"H Zhou","year":"2004","unstructured":"Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W, Dixit VM (2004) Bcl10 activates the NF-[kappa]B pathway through ubiquitination of NEMO. Nature 427:167\u2013171","journal-title":"Nature"},{"key":"2313_CR66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","volume":"27","author":"R D\u00e8offinger","year":"2001","unstructured":"D\u00e8offinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Isra\u00e8el A, Courtois G, Casanova JL (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27:277\u2013285","journal-title":"Nat Genet"},{"key":"2313_CR67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2332\/allergolint.12-RAI-0446","volume":"61","author":"T Kawai","year":"2012","unstructured":"Kawai T, Nishikomori R, Heike T (2012) Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol Int 61:207\u2013217","journal-title":"Allergol Int"},{"key":"2313_CR68","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00431-010-1206-7","volume":"169","author":"CM Roberts","year":"2010","unstructured":"Roberts CM, Angus JE, Leach IH, McDermott EM, Walker DA, Ravenscroft JC (2010) A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID). Eur J Pediatr 169:1403\u20131407","journal-title":"Eur J Pediatr"},{"key":"2313_CR69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12026-008-8085-2","volume":"44","author":"P Permaul","year":"2009","unstructured":"Permaul P, Narla A, Hornick JL, Pai SY (2009) Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes. Immunol Res 44:89\u201398","journal-title":"Immunol Res"},{"key":"2313_CR70","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/hmg\/11.20.2371","volume":"11","author":"A Smahi","year":"2002","unstructured":"Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, Casanova JL, Israel A (2002) The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11:2371\u20132375","journal-title":"Hum Mol Genet"},{"key":"2313_CR71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y","volume":"99","author":"S Mansour","year":"2001","unstructured":"Mansour S, Woffendin H, Mitton S, Jeffery I, Jakins T, Kenwrick S, Murday VA (2001) Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 99:172\u2013177","journal-title":"Am J Med Genet"},{"key":"2313_CR72","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/76006","volume":"25","author":"GR Bignell","year":"2000","unstructured":"Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van Den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160\u2013165","journal-title":"Nat Genet"},{"key":"2313_CR73","doi-asserted-by":"crossref","first-page":"17971","DOI":"10.1016\/S0021-9258(19)37138-8","volume":"267","author":"A Krikos","year":"1992","unstructured":"Krikos A, Laherty CD, Dixit VM (1992) Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem 267:17971\u201317976","journal-title":"J Biol Chem"},{"key":"2313_CR74","doi-asserted-by":"crossref","first-page":"36171","DOI":"10.1074\/jbc.M406638200","volume":"279","author":"H Jono","year":"2004","unstructured":"Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD (2004) NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem 279:36171\u201336174","journal-title":"J Biol Chem"},{"key":"2313_CR75","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350\u20132354","journal-title":"Science"},{"key":"2313_CR76","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI34257","volume":"118","author":"W Jin","year":"2008","unstructured":"Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 118:1858\u20131866","journal-title":"J Clin Invest"},{"key":"2313_CR77","doi-asserted-by":"crossref","first-page":"37409","DOI":"10.1074\/jbc.M307416200","volume":"278","author":"B Ciani","year":"2003","unstructured":"Ciani B, Layfield R, Cavey JR, Sheppard PW, Searle MS (2003) Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J Biol Chem 278:37409\u201337412","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"2313_CR78","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2091-8-S1-S5","volume":"8","author":"R Layfield","year":"2007","unstructured":"Layfield R, Shaw B (2007) Ubiquitin-mediated signalling and Paget's disease of bone. BMC Biochem 8(Suppl 1):S5","journal-title":"BMC Biochem"},{"key":"2313_CR79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","volume":"20","author":"J Xu","year":"2009","unstructured":"Xu J, Wu HF, Ang ES, Yip K, Woloszyn M, Zheng MH, Tan RX (2009) NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev 20:7\u201317","journal-title":"Cytokine Growth Factor Rev"},{"key":"2313_CR80","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ng.874","volume":"43","author":"M Matmati","year":"2011","unstructured":"Matmati M, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M, Geboes L, Louagie E, Mc Guire C, Vereecke L, Chu Y, Boon L, Staelens S, Matthys P, Lambrecht BN, Schmidt-Supprian M, Pasparakis M, Elewaut D, Beyaert R, van Loo G (2011) A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43:908\u2013912","journal-title":"Nat Genet"},{"key":"2313_CR81","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889\u2013901","journal-title":"Dev Cell"},{"key":"2313_CR82","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2298","volume":"9","author":"T Kubota","year":"2007","unstructured":"Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K (2007) NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Arthritis Res Ther 9:R97","journal-title":"Arthritis Res Ther"},{"key":"2313_CR83","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/MCB.00299-08","volume":"28","author":"H Fukushima","year":"2008","unstructured":"Fukushima H, Nakao A, Okamoto F, Shin M, Kajiya H, Sakano S, Bigas A, Jimi E, Okabe K (2008) The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol 28:6402\u20136412","journal-title":"Mol Cell Biol"},{"key":"2313_CR84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, Takayanagi H (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202:1261\u20131269","journal-title":"J Exp Med"},{"key":"2313_CR85","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","volume":"208","author":"EF Wagner","year":"2005","unstructured":"Wagner EF, Eferl R (2005) Fos\/AP-1 proteins in bone and the immune system. Immunol Rev 208:126\u2013140","journal-title":"Immunol Rev"},{"key":"2313_CR86","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","volume":"118","author":"AO Aliprantis","year":"2008","unstructured":"Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, Ostrowski MC, Olsen BR, Glimcher LH (2008) NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest 118:3775\u20133789","journal-title":"J Clin Invest"},{"key":"2313_CR87","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","volume":"282","author":"T Yamashita","year":"2007","unstructured":"Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF (2007) NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 282:18245\u201318253","journal-title":"J Biol Chem"},{"key":"2313_CR88","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","volume":"279","author":"K Matsuo","year":"2004","unstructured":"Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF (2004) Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279:26475\u201326480","journal-title":"J Biol Chem"},{"key":"2313_CR89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.coph.2009.06.007","volume":"9","author":"Y Abu-Amer","year":"2009","unstructured":"Abu-Amer Y (2009) Inflammation, cancer, and bone loss. Curr Opin Pharmacol 9:427\u2013433","journal-title":"Curr Opin Pharmacol"},{"key":"2313_CR90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S (2011) NF-kappaB, inflammation, and metabolic disease. Cell Metab 13:11\u201322","journal-title":"Cell Metab"},{"key":"2313_CR91","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cr.2008.30","volume":"18","author":"M Karin","year":"2008","unstructured":"Karin M (2008) The I[kappa]B kinase\u2014a bridge between inflammation and cancer. Cell Res 18:334\u2013342","journal-title":"Cell Res"},{"key":"2313_CR92","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1357-2725(03)00259-0","volume":"36","author":"SE Sweeney","year":"2004","unstructured":"Sweeney SE, Firestein GS (2004) Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 36:372\u2013378","journal-title":"Int J Biochem Cell Biol"},{"key":"2313_CR93","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10165-005-0412-z","volume":"15","author":"DM Findlay","year":"2005","unstructured":"Findlay DM, Haynes DR (2005) Mechanisms of bone loss in rheumatoid arthritis. Mod Rheumatol 15:232\u2013240","journal-title":"Mod Rheumatol"},{"key":"2313_CR94","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"2313_CR95","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2166","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett G (2007) Erosive arthritis. Arthritis Res Ther 9(Suppl 1):S2","journal-title":"Arthritis Res Ther"},{"key":"2313_CR96","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"289","author":"GA Rodan","year":"2000","unstructured":"Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289:1508\u20131514","journal-title":"Science"},{"key":"2313_CR97","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","volume":"2","author":"M Feldmann","year":"2002","unstructured":"Feldmann M (2002) Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2:364\u2013371","journal-title":"Nat Rev Immunol"},{"key":"2313_CR98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14712598.2.2.135","volume":"2","author":"C Gabay","year":"2002","unstructured":"Gabay C (2002) Cytokine inhibitors in the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2:135\u2013149","journal-title":"Expert Opin Biol Ther"},{"key":"2313_CR99","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002281-200305000-00016","volume":"15","author":"T Nakashima","year":"2003","unstructured":"Nakashima T, Wada T, Penninger J (2003) RANKL and RANK as novel therapeutic targets for arthritis. Curr Op Rheum 15:280\u2013287","journal-title":"Curr Op Rheum"},{"key":"2313_CR100","first-page":"S179","volume":"21","author":"T Pincus","year":"2003","unstructured":"Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS (2003) Methotrexate as the \u201canchor drug\u201d for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21:S179\u2013S185","journal-title":"Clin Exp Rheumatol"},{"key":"2313_CR101","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","volume":"2","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2:473\u2013488","journal-title":"Nat Rev Drug Discov"},{"key":"2313_CR102","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.20050640","volume":"201","author":"CA Dinarello","year":"2005","unstructured":"Dinarello CA (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201:1355\u20131359","journal-title":"J Exp Med"},{"key":"2313_CR103","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R, Denosumab Rheumatoid Arthritis Study Group (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 58:1299\u20131309 [see comment]","journal-title":"Arthritis Rheum"},{"key":"2313_CR104","first-page":"133","volume":"1","author":"Y Abu-Amer","year":"2006","unstructured":"Abu-Amer Y, Faccio R (2006) Therapeutic approaches in bone pathogeneses: targeting the IKK\/NF-kB axis. Future Med 1:133\u2013146","journal-title":"Future Med"},{"key":"2313_CR105","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4049\/jimmunol.163.3.1577","volume":"163","author":"R Seetharaman","year":"1999","unstructured":"Seetharaman R, Mora AL, Nabozny G, Boothby M, Chen J (1999) Essential role of T cell NF-kappa B activation in collagen-induced arthritis. J Immunol 163:1577\u20131583","journal-title":"J Immunol"},{"key":"2313_CR106","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.4049\/jimmunol.171.10.5547","volume":"171","author":"JC Clohisy","year":"2003","unstructured":"Clohisy JC, Roy BC, Biondo C, Frazier E, Willis D, Teitelbaum SL, Abu-Amer Y (2003) Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis. J Immunol 171:5547\u20135553","journal-title":"J Immunol"},{"key":"2313_CR107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5507\/bp.2002.004","volume":"146","author":"J Gallo","year":"2002","unstructured":"Gallo J, Kam\u00e2inek P, Tich\u00e2a V, Rih\u00e2akov\u00e2a P, Ditmar R (2002) Particle disease. A comprehensive theory of periprosthetic osteolysis: a review. Biomed Pap Med Fac Univ Palack\u00e2y Olomouc Czech Repub 146:21\u201328","journal-title":"Biomed Pap Med Fac Univ Palack\u00e2y Olomouc Czech Repub"},{"issue":"Suppl 1","key":"2313_CR108","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/ar2170","volume":"9","author":"Y Abu-Amer","year":"2007","unstructured":"Abu-Amer Y, Darwech I, Clohisy JC (2007) Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 9(Suppl 1):S6","journal-title":"Arthritis Res Ther"},{"key":"2313_CR109","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.blo.0000238813.95035.1b","volume":"454","author":"PE Purdue","year":"2007","unstructured":"Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP (2007) The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 454:251\u2013261","journal-title":"Clin Orthop Relat Res"},{"key":"2313_CR110","doi-asserted-by":"crossref","first-page":"23735","DOI":"10.1074\/jbc.M111.223669","volume":"286","author":"Y Yamanaka","year":"2011","unstructured":"Yamanaka Y, Karuppaiah K, Abu-Amer Y (2011) Polyubiquitination events mediate polymethylmethacrylate (PMMA) particle activation of NF-kappaB pathway. J Biol Chem 286:23735\u201323741","journal-title":"J Biol Chem"},{"key":"2313_CR111","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jor.21555","volume":"30","author":"M Alhawagri","year":"2012","unstructured":"Alhawagri M, Yamanaka Y, Ballard D, Oltz E, Abu-Amer Y (2012) Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis. J Orthop Res 30:554\u2013560","journal-title":"J Orthop Res"},{"key":"2313_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000464","volume":"9","author":"R Layfield","year":"2007","unstructured":"Layfield R (2007) The molecular pathogenesis of Paget disease of bone. Expert Rev Mol Med 9:1\u201313","journal-title":"Expert Rev Mol Med"},{"key":"2313_CR113","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm1701","volume":"6","author":"L Hicke","year":"2005","unstructured":"Hicke L, Schubert HL, Hill CP (2005) Ubiquitin-binding domains. Nat Rev Mol Cell Biol 6:610\u2013621","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2313_CR114","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/emboj\/19.7.1576","volume":"19","author":"L Sanz","year":"2000","unstructured":"Sanz L, Diaz-Meco MT, Nakano H, Moscat J (2000) The atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway. EMBO J 19:1576\u20131586","journal-title":"EMBO J"},{"key":"2313_CR115","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1902\/jop.2008.080233","volume":"79","author":"DL Cochran","year":"2008","unstructured":"Cochran DL (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79:1569\u20131576","journal-title":"J Periodontol"},{"key":"2313_CR116","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10103-010-0864-z","volume":"26","author":"RR Oliveira de","year":"2011","unstructured":"de Oliveira RR, Novaes AB Jr, Garlet GP, de Souza RF, Taba M Jr, Sato S, de Souza SL, Palioto DB, Grisi MF, Feres M (2011) The effect of a single episode of antimicrobial photodynamic therapy in the treatment of experimental periodontitis. Microbiological profile and cytokine pattern in the dog mandible. Lasers Med Sci 26:359\u2013367","journal-title":"Lasers Med Sci"},{"key":"2313_CR117","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/np100547b","volume":"74","author":"M Feldman","year":"2011","unstructured":"Feldman M, Tanabe S, Epifano F, Genovese S, Curini M, Grenier D (2011) Antibacterial and anti-inflammatory activities of 4-hydroxycordoin: potential therapeutic benefits. J Nat Prod 74:26\u201331","journal-title":"J Nat Prod"},{"key":"2313_CR118","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2249.2007.03342.x","volume":"148","author":"MR Milward","year":"2007","unstructured":"Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR (2007) Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 148:307\u2013324","journal-title":"Clin Exp Immunol"},{"key":"2313_CR119","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.micpath.2004.10.003","volume":"37","author":"GT Huang","year":"2004","unstructured":"Huang GT, Zhang HB, Dang HN, Haake SK (2004) Differential regulation of cytokine genes in gingival epithelial cells challenged by Fusobacterium nucleatum and Porphyromonas gingivalis. Microb Pathog 37:303\u2013312","journal-title":"Microb Pathog"},{"key":"2313_CR120","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1172\/JCI119679","volume":"100","author":"Y Abu-Amer","year":"1997","unstructured":"Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL (1997) Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557\u20131565","journal-title":"J Clin Invest"},{"key":"2313_CR121","first-page":"113","volume":"12","author":"RK McCormick","year":"2007","unstructured":"McCormick RK (2007) Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. Altern Med Rev 12:113\u2013145","journal-title":"Altern Med Rev"},{"key":"2313_CR122","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","volume":"65","author":"GR Mundy","year":"2007","unstructured":"Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65:S147\u2013S151","journal-title":"Nutr Rev"},{"key":"2313_CR123","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/er.23.3.279","volume":"23","author":"BL Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279\u2013302","journal-title":"Endocr Rev"},{"key":"2313_CR124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1677\/jme.0.0260079","volume":"26","author":"R Rizzoli","year":"2001","unstructured":"Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79\u201394","journal-title":"J Mol Endocrinol"},{"key":"2313_CR125","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/MCB.15.9.4971","volume":"15","author":"B Stein","year":"1995","unstructured":"Stein B, Yang MX (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C\/EBP beta. Mol Cell Biol 15:4971\u20134979","journal-title":"Mol Cell Biol"},{"key":"2313_CR126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s007740170046","volume":"19","author":"T Sugiyama","year":"2001","unstructured":"Sugiyama T (2001) Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis. J Bone Miner Metab 19:89\u201396","journal-title":"J Bone Miner Metab"},{"key":"2313_CR127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tem.2005.01.004","volume":"16","author":"D Kalaitzidis","year":"2005","unstructured":"Kalaitzidis D, Gilmore TD (2005) Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab 16:46\u201352","journal-title":"Trends Endocrinol Metab"},{"key":"2313_CR128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mehy.2010.09.023","volume":"76","author":"P Lencel","year":"2011","unstructured":"Lencel P, Magne D (2011) Inflammaging: the driving force in osteoporosis? Med Hypotheses 76:317\u2013321","journal-title":"Med Hypotheses"},{"key":"2313_CR129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.rdc.2006.07.004","volume":"32","author":"E Romas","year":"2006","unstructured":"Romas E, Gillespie MT (2006) Inflammation-induced bone loss: can it be prevented? Rheum Dis Clin North Am 32:759\u2013773","journal-title":"Rheum Dis Clin North Am"},{"key":"2313_CR130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/gut.2006.117382","volume":"57","author":"H Tilg","year":"2008","unstructured":"Tilg H, Moschen AR, Kaser A, Pines A, Dotan I (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57:684\u2013694","journal-title":"Gut"},{"key":"2313_CR131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.mca.0000131573.31966.34","volume":"15","author":"J Davignon","year":"2004","unstructured":"Davignon J, Jacob RF, Mason RP (2004) The antioxidant effects of statins. Coron Artery Dis 15:251\u2013258","journal-title":"Coron Artery Dis"},{"key":"2313_CR132","first-page":"7","volume":"2012","author":"AS Nazrun","year":"2012","unstructured":"Nazrun AS, Norazlina M, Norliza M, Nirwana SI (2012) The anti-inflammatory role of vitamin E in prevention of osteoporosis. Adv Pharmacol Sci 2012:7","journal-title":"Adv Pharmacol Sci"},{"key":"2313_CR133","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3858\/emm.2011.43.11.067","volume":"43","author":"HJ Moon","year":"2011","unstructured":"Moon HJ, Kim SE, Yun YP, Hwang YS, Bang JB, Park JH, Kwon IK (2011) Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species. Exp Mol Med 43:605\u2013612","journal-title":"Exp Mol Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2313-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2313-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T22:54:23Z","timestamp":1715036063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2313-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":133,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2313-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,7]]}}}